Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Jung Kim

Jung Kim, Ph.D.

Staff Scientist
Clinical Genetics Branch

NCI Shady Grove

240-276-6627
|
jung.kim2@nih.gov

Jung Kim joined the Clinical Genetics Branch (CGB) as a postdoctoral fellow in 2016, was promoted to research fellow in 2019, and was appointed staff scientist in 2021. Dr. Kim earned her Ph.D. in cancer biology from the Driskill Graduate Program in Life Sciences at Northwestern University, Chicago, Illinois, in 2015, after which she completed a one-year T-32 NRSA postdoctoral fellowship in the Division of Hematology and Oncology. Her doctoral and postdoctoral research focused on the transcriptional regulation of key signaling pathways in prostate cancer, including miRNA and epigenetic regulators.

Flow diagram of AutoGVP. (A) Required input files for custom or CAVATICA workflow. (B) Variant classification method decision tree. (C) Alluvial plot showing how InterVar classification changes in AutoGVP.
Automated Germline Variant Pathogenicity (AutoGVP)

AutoGVP integrates ClinVar variant classification with modified InterVar classification to output germline variant classification.

Dr. Kim works with Douglas Stewart, M.D., senior investigator, to understand the germline genetics of cancer susceptibility genes and associated pathways using the genome-first approach, especially focusing on DICER1 and associated miRNA processing genes, and to analyze somatic genomic data of DICER1-associated malignancies.

She is the co-developer of the Automated Germline Variant Pathogencity (AutoGVP) tool. 

Email